MedTrace Logo

The Effect of IV NSAID's and Corticosteroids on Dysphasia and Dysphonia Following ASDF

NCT04650893 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2024-08-23

Study results available
· View outcomes & findings →

Summary

This study is to assess the efficacy of intra-operative intravenous non-steroidal anti-inflammatory drug (Ketorolac) versus intravenous (dexamethasone) administration on dysphagia and dysphonia after anterior cervical discectomy and fusion (ACDF).

Conditions

Interventions

DRUG

Intravenous Ketorolac

To assess the efficacy of the meds for dysphagia and dysphonia following ACDF

DRUG

Intravenous Dexamethasone

To assess the efficacy of the meds for dysphagia and dysphonia following ACDF

DRUG

Placebo

Control

Sponsors & Collaborators

  • University of Nebraska

    lead OTHER

Principal Investigators

  • Kevin Garvin, MD · University of Nebraska

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-02
Primary Completion
2023-12-08
Completion
2023-12-08
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04650893 on ClinicalTrials.gov